Patent intelligence · CA
CA 2870399
POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES
POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES
Patent details — CA 2870399
- Jurisdiction
- CA
- Status
- granted
- Grant date
- Oct 24, 2013
- Expiration
- Oct 19, 2033
- Applicant
- ALK ABELLO AS [DK]
- CPC classes
- A61K 39/ 35 A I, A61K 39/ 36 A I, A61K/3935, A61K/3936
Quick answer
CA 2870399 (POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES) is held by ALK ABELLO AS [DK]. Status: granted. Granted Oct 24, 2013. Expires Oct 19, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ALK ABELLO AS [DK]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 39/ 35 A I, A61K 39/ 36 A I, A61K/3935, A61K/3936, A61P/3702
More from ALK ABELLO AS [DK]
Related pharmaceutical patents in our USPTO index.
-
WO 2024200854
ANTICORPS DE LIAISON AUX ALLERGÈNES APPROPRIÉS POUR TRAITER DES ALLERGIES AU POLLEN D'ARBRE
granted -
EP 4302751
ORALE DÜNNFILME MIT GERINGER WASSERAKTIVITÄT
granted -
EP 4302750
ORALE DÜNNFILME ENTHALTEND ADRENALIN
granted -
CA 3259886
DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI
granted -
WO 2023232958
INHIBITEURS DE LA KINASE DE BRUTON POUR LE TRAITEMENT D'UNE RÉACTION ALLERGIQUE SOUDAINE
granted -
CA 3255134
COMPOSITION D'ALLERGÈNE D'ARACHIDE
granted -
WO 2019224246
MÉTHODES FONDÉES SUR DES BIOMARQUEURS DESTINÉES AU TRAITEMENT D'UNE MALADIE ATOPIQUE PAR IMMUNOTHÉRAPIE
granted -
HK 1249412
PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF
granted
Frequently asked questions
What is US patent 2870399?
CA 2870399 (POLYPEPTIDES DE PROFILINE VEGETALE DESTINES A ETRE UTILISES DANS L'IMMUNOTHERAPIE NON SPECIFIQUE D'ALLERGIES) is held by ALK ABELLO AS [DK]. Status: granted. Granted Oct 24, 2013. Expires Oct 19, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns CA 2870399?
ALK ABELLO AS [DK] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does CA 2870399 expire?
Our index shows an expiration date of Oct 19, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.